Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-31
DOI
10.1016/j.jhep.2023.10.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
- (2022) Jian-Hua Li et al. Hepatobiliary & Pancreatic Diseases International
- GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors
- (2022) Yunzheng Li et al. CANCER RESEARCH
- Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma
- (2022) Ying Zhu et al. Hepatobiliary & Pancreatic Diseases International
- Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression
- (2022) Xiangqi Meng et al. ONCOGENE
- Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer
- (2022) Hannah N. Bell et al. Cell Metabolism
- Clinical heterogeneity of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in thirteen palestinian patients and report of a novel variant in the SLC25A15 gene
- (2022) Imad Dweikat et al. Frontiers in Genetics
- Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma
- (2021) Qiangnu Zhang et al. Aging-US
- A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma
- (2021) Qiangnu Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- 4‐phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR‐α
- (2021) Shu‐Zhen Chen et al. Clinical and Translational Medicine
- Discovery of a CPS1‐deficient HCC subtype with therapeutic potential via integrative genomic and experimental analysis
- (2021) Tong Wu et al. HEPATOLOGY
- Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
- (2021) Danyu Du et al. Acta Pharmaceutica Sinica B
- Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
- (2021) Liping Wang et al. Frontiers in Molecular Biosciences
- PGC1α suppresses metastasis of HCC by inhibiting Warburg effect via PPARγ‐dependent WNT/β‐catenin/PDK1 axis
- (2020) Qiaozhu Zuo et al. HEPATOLOGY
- PLAGL2‐EGFR‐HIF‐1/2α signaling loop promotes HCC progression and Erlotinib insensitivity
- (2020) Weiwei Hu et al. HEPATOLOGY
- A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
- (2020) Haojie Jin et al. eLife
- p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis
- (2019) Le Li et al. NATURE
- Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion
- (2019) Yin Cao et al. JOURNAL OF PROTEOME RESEARCH
- Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer
- (2019) Mohammad Khalaj-kondori et al. CURRENT PROBLEMS IN CANCER
- Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR‐338‐3p/PKM2 Axis Under Hypoxic Stress
- (2019) Qing Li et al. HEPATOLOGY
- A Novel oxoglutarate dehydrogenase-like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis
- (2019) Yao Liu et al. CLINICAL CANCER RESEARCH
- Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP degradation
- (2019) Liang Deng et al. ONCOGENE
- Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR‐29a‐3p
- (2019) Zhe Kong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
- (2019) Guofeng Ma et al. MOLECULAR CANCER RESEARCH
- A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
- (2019) Hee Chan Yoo et al. Cell Metabolism
- Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women
- (2019) Xingyi Guo et al. INTERNATIONAL JOURNAL OF CANCER
- OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism
- (2019) W.Q. Dai et al. JOURNAL OF HEPATOLOGY
- Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis
- (2018) Shu-meng Ji M S-MEDECINE SCIENCES
- Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
- (2018) Binghua Li et al. EBioMedicine
- Hypoxia reduces HNF4α/MODY1 protein expression in pancreatic β-cells by activating AMP-activated protein kinase
- (2017) Yoshifumi Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
- (2017) Mi-Jin Kim et al. MOLECULAR CANCER RESEARCH
- CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
- (2017) Jiyeon Kim et al. NATURE
- Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
- (2017) Jessica B. Spinelli et al. SCIENCE
- Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
- (2017) Hayden Weng Siong Tan et al. Nature Communications
- SIRT5 regulation of ammonia-induced autophagy and mitophagy
- (2015) Lucia Polletta et al. Autophagy
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
- (2015) M van Geldermalsen et al. ONCOGENE
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis
- (2011) Fei Liu et al. LIVER INTERNATIONAL
- Hepatocyte Nuclear Factor 4 Suppresses the Development of Hepatocellular Carcinoma
- (2010) B.-F. Ning et al. CANCER RESEARCH
- Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
- (2009) T.L. Lam et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started